MANGALAM GLOBAL ENTERPRISE
Back to Income Statement
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,281 Cr | ₹1,839 Cr | ₹1,424 Cr | ₹1,279 Cr | ₹960 Cr |
What is the latest Revenue of MANGALAM GLOBAL ENTERPRISE ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,281 Cr |
| Mar2024 | ₹1,839 Cr |
| Mar2023 | ₹1,424 Cr |
| Mar2022 | ₹1,279 Cr |
| Mar2021 | ₹960 Cr |
How is Revenue of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,281 Cr | 24.09 | |
| Mar2024 | ₹1,839 Cr | 29.09 | |
| Mar2023 | ₹1,424 Cr | 11.36 | |
| Mar2022 | ₹1,279 Cr | 33.24 | |
| Mar2021 | ₹960 Cr | - | |
Compare Revenue of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹397.2 Cr | -13.4% | -20% | -8.9% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,880.2 Cr | 0.2% | -1% | -9.5% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,572.9 Cr | -2% | -8.9% | -0.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,189.1 Cr | 1.2% | 9% | -7.7% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,042.8 Cr | -3.6% | -1.3% | -29.8% | Stock Analytics | |
| INDO US BIOTECH | ₹229.1 Cr | -1.1% | -8.6% | -55.4% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | -13.4% |
-20% |
-8.9% |
| SENSEX | -1.9% |
-2.2% |
7.4% |
You may also like the below Video Courses